Emmes, a global, full-service CRO has appointed Ching Tian as chief innovation officer.   Emmes Chief Executive Officer Dr. Christine Dingivan said, “Ching brings a wealth of data and digital experience, which will be immediately useful as we accelerate our transition to decentralized trials. Her role is to work across the company to integrate technology and processes that strengthen the way we’ll address clinical trials of the future.”   Ching Tian, chief innovation officer Tian said...